Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Biosimilars in oncology: key role of nurses in patient education (CROSBI ID 286015)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Waller, Cornelius F ; Friganović, Adriano Biosimilars in oncology: key role of nurses in patient education // Future Oncology, 16 (2020), 25; 1931-1939. doi: 10.2217/fon-2020-0486

Podaci o odgovornosti

Waller, Cornelius F ; Friganović, Adriano

engleski

Biosimilars in oncology: key role of nurses in patient education

Biosimilars have the potential to lower costs and increase patient access to life-saving cancer therapies. However, lack of familiarity with biosimilars can be a barrier to their adoption, limiting their health and economic benefits. As highly trusted healthcare providers, nurses play integral roles in patient education. This review aims to help prepare nurses to respond to potential questions from patients on biosimilars. The regulation, use and potential benefits of biosimilars are discussed, with a focus on biosimilars in oncology. Overall, biosimilars are highly regulated medicines that provide comparable benefits to available biologics. Nurses can influence the adoption of biosimilars through patient education and can impact the future of the field in their expanding roles within health care systems.

biologics ; biosimilars ; cancer care ; nurse

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

16 (25)

2020.

1931-1939

objavljeno

1479-6694

10.2217/fon-2020-0486

Povezanost rada

nije evidentirano

Poveznice
Indeksiranost